Type I Interferon Receptor Antagonists [MoA] class drugs

1 result
  • saphnelo - anifrolumab - fnia injection, solution

    (Anifrolumab-Fnia)
    Astrazeneca Pharmaceuticals Lp
    Saphnelo treats moderate to severe systemic lupus erythematosus (SLE) in adults receiving standard therapy. Not recommended for patients with severe active lupus nephritis or severe active central nervous system lupus.